Slate Pharmaceuticals, Inc. — Form D/A
Slate Pharmaceuticals, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2010-01-29. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-01-29
- Form: D/A
- Accession: 0001469231-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.8M
- Amount sold: $2.8M
- Minimum investment: $1
- Investors: 33
- Date of first sale: 2009-08-07
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-133739
Issuer
- Name: Slate Pharmaceuticals, Inc.
- CIK: 0001469231
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 318 BLACKWELL STREET, DURHAM, NC, 27701
- Phone: 919.682.8800
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| MIchael Ford | Director | Austin, TX |
| Anthony Wild | Director | Columbus, OH |
| Trygve Mikkelsen | Director | Encinitas, CA |
| Richard Robert DeSchutter | Director | Raleigh, NC |
| Trygve Robert Mikkelsen | Director | Raleigh, NC |
| Anthony Robert Wild | Director | Raleigh, NC |
| Robert Stanley Whitehead | Director | Durham, NC |
| Robert Stanley Whitehead | Executive Officer | Durham, NC |
| Douglas Stanley Eckert | Director | Durham, NC |
| Michael Stanley Ford | Director | Durham, NC |
| William Robert Dahl | Director | Durham, NC |
| Kenneth Ramsey Couch | Director | Durham, NC |
| Richard DeSchutter | Director | Durham, NC |
| Douglas Eckert | Director | Durham, NC |
Other filings by this issuer (3)
More